DDL 2024

We look forward to meeting you in Edinburgh at DDL 2024, Drug Delivery to the Lungs. Request a meeting or stop by booth 174 to learn how our team can support the development of your inhaled product.

POSTER

USP <601> and <1604> Give Different APSD Results

Christopher J Gruenloh, Ian Carter, Jamie Clayton, William H Doub, Adrian P Goodey, Svetlana Lyapustina, Jolyon P Mitchell, & Daryl L Roberts

This poster opens the “black box” to explore ramifications of a significant change in the calculational methodology for APSD-derived metrics (e.g., MMAD and FPF) associated with the recent launch of informative USP Chapter <1604> compared with the practice in pre-2015 USP Chapter <601>.